How Healthcare Organizations Are Navigating Compliance Challenges during the COVID Pandemic

 

The COVID-19 pandemic has strained healthcare systems and those who work in them all over the world.

But, with more patients and more work, there cannot be a reduction in standards or compliance.

Rich Feczko, National Director of Standards & Innovation for Compass One Healthcare, is one of many mourning the recent loss of loved ones in this period. Though his family members did not pass because of COVID, he said importance of the work he does comes into focus after being reminded of the human side of care.

“It does hit home. Generalizing my own thoughts with regards to our intelligent response as an organization and bringing that approach, not only from a technology and manual application, but really from a human standpoint, heightens awareness and really heightens purpose,” Feczsko said.

That means making sure products and devices do what they need to do and are compliant with the needs of those working in the industry. That’s what Compass One found in Surfacide.

“As an early adopter to using UV-C technology, up until the time Surfacide came to life, if you will, the entire industry was sequestered to using single-emitter UV-C. [It] had limited capabilities, although UV-C had already been validated by several leading epidemiologists and infection preventionists in the industry,” he said. “What we were able to do with Surfacide in our partnership was to utilize Surfacide in the UVC system, and the three-emitter system they provide, in a more intelligent way.”

Follow us on social media for the latest updates in B2B!

Latest

NRF 2022 Retail's Big Show
What’s in the Shopping Cart for the 2022 National Retail Federation’s Big Show?
January 14, 2022
 In just a few short days, from January 16th through the 18th, the National Retail Federation will launch Retail’s Big Show in the shopping capital of the world, New York City. As retail Read more
Schools Struggle to Reach Their Education Technology Goals. Here’s Why and How To Fix It.
January 14, 2022
As we hit the two-year mark of the COVID-19 pandemic, the education sector continues to struggle in adjusting to virtual and hybrid education at scale. In 2020, McKinsey estimated that, due to COVID Read more
85% of Clinical Drug Trials Face Delays. What's the True Cost?
85% of Clinical Drug Trials Face Delays. What’s the True Cost?
January 14, 2022
  Clinical trials can save lives and provide new ways to treat disease. The industry estimates that 85% of all clinical trials face delays due to patient enrollment. Understanding that challenge Read more